EP1536009A4
Hla-a24-restricted cancer antigen peptide
47 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12 Sheet 13 Sheet 14 Sheet 15 Sheet 16 Sheet 17 Sheet 18 Sheet 19 Sheet 20 Sheet 21 Sheet 22 Sheet 23 Sheet 24 Sheet 25 Sheet 26 Sheet 27 Sheet 28 Sheet 29 Sheet 30 Sheet 31 Sheet 32 Sheet 33 Sheet 34 Sheet 35 Sheet 36 Sheet 37 Sheet 38 Sheet 39 Sheet 40 Sheet 41 Sheet 42 Sheet 43 Sheet 44 Sheet 45 Sheet 46 Sheet 47
Every citation, both waysCites: the store holds 0 of 1
| Reference | Relation | Cited during |
|---|---|---|
| OKA Y ET AL: "HUMAN CYTOTOXIC T-LYMPHOCYTE RESPONSES SPECIFIC FOR PEPTIDES OF THEWILD-TYPE WILMS' TUMOR GENE (WT1) PRODUCT", IMMUNOGENETICS, SPRINGER VERLAG, BERLIN, DE, vol. 51, no. 2, 1 February 2000 (2000-02-01), pages 99 - 107, XP000884935, ISSN: 0093-7711 | Non-patent | Search report |
24 members in 11 offices
Priority claims14
| Document | Office | Kind | Date |
|---|---|---|---|
| 2002171518 | Japan | A | |
| 2002171518 | Japan | A | |
| 2002171518 | Japan | – | |
| 2002275572 | Japan | A | |
| 2002275572 | Japan | A | |
| 2002275572 | Japan | – | |
| 0307463 | Japan | W | |
| 0307463 | Japan | W | |
| 2002171518 | – | – | – |
| 2002275572 | – | – | – |
| JP20020171518 | – | – | – |
| JP20020275572 | – | – | – |
| JP2003007463 | – | – | – |
| WO2003JP07463 | – | – | – |
Members24
| Document | Office | Kind | |
|---|---|---|---|
| CA2489227A1 | Canada | A1 | |
| WO03106682A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2003242305A1 | Australia | A1 | |
| AU2003242305A8 | Australia | A8 | |
| KR20050010913A | Republic of Korea | A | |
| EP1536009A1 | European Patent Office (EPO) | A1 | |
| CN1675362A | China | A | |
| JPWO2003106682A1 | Japan | A1 | |
| EP1536009A4This record | European Patent Office (EPO) | A4 | |
| HK1083866A | Hong Kong, China | A | |
| US2007082860A1 | United States of America | A1 | |
| CN101113163A | China | A | |
| CN100408683C | China | C | |
| US7420034B2 | United States of America | B2 | |
| US2009099090A1 | United States of America | A1 | |
| JP4365784B2 | Japan | B2 | |
| US7666985B2 | United States of America | B2 | |
| EP1536009B1 | European Patent Office (EPO) | B1 | |
| AT466084T | Austria | T | |
| ATE466084T1 | Austria | T1 | |
| DE60332355D1 | Germany | D1 | |
| CN101113163B | China | B | |
| KR101050703B1 | Republic of Korea | B1 | |
| CA2489227C | Canada | C |
92 legal events, as 7 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal feeWithdrawnR119 | R119 | DE | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Fee paymentPLFP | PLFP | FR | |
| Partial transmission of propertyTQ | TQ | FR | |
| Partial transmission of propertyTQ | TQ | FR | |
| Partial transmission of propertyTQ | TQ | FR | |
| Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)REGISTERED BETWEEN 20170928 AND 20171004732E | 732E | GB | |
| Change of applicant/patenteeR081 | R081 | DE | |
| Change of representativeR082 | R082 | DE | |
| Fee paymentPLFP | PLFP | FR | |
| Partial transmission of propertyTQ | TQ | FR | |
| Partial transmission of propertyTQ | TQ | FR | |
| Partial transmission of propertyTQ | TQ | FR | |
| Partial transmission of propertyTQ | TQ | FR | |
| Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)REGISTERED BETWEEN 20160519 AND 20160525732E | 732E | GB | |
| Change of applicant/patenteeR081 | R081 | DE | |
| Change of applicant/patenteeR081 | R081 | DE | |
| Change of applicant/patenteeR081 | R081 | DE | |
| Change of applicant/patenteeR081 | R081 | DE | |
| Change of representativeR082 | R082 | DE | |
| Fee paymentPLFP | PLFP | FR | |
| Change of name or company nameCD | CD | FR | |
| Change of name or company nameCD | CD | FR | |
| Change of name or company nameCD | CD | FR | |
| Change of applicant/patenteeR081 | R081 | DE | |
| Change of applicant/patenteeR081 | R081 | DE | |
| Change of applicant/patenteeR081 | R081 | DE | |
| Change of applicant/patenteeR081 | R081 | DE | |
| Change of applicant/patenteeR081 | R081 | DE | |
| Change of applicant/patenteeR081 | R081 | DE | |
| Change of applicant/patenteeR081 | R081 | DE | |
| Change of applicant/patenteeR081 | R081 | DE | |
| Change of representativeR082 | R082 | DE | |
| Change of representativeR082 | R082 | DE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Discontinued in the netherlands as no translation has been filedVDEP | VDEP | NL | |
| Corresponds to:REF | REF | EP | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Designated contracting statesAK | AK | EP | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| First examination report despatched17Q | 17Q | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Supplementary search report drawn up and despatchedA4 | A4 | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Request for extension of the european patent (deleted)DAX | DAX | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 1536009
- Publication, DOCDB
- 1536009
- Publication, EPODOC
- EP1536009
- Application
- 3736167
- Application, DOCDB
- 03736167
- Application, EPODOC
- EP20030736167
Titles3
- German
- HLA-A24-RESTRINGIERTES KREBSANTIGENPEPTID
- English
- HLA-A24-RESTRICTED CANCER ANTIGEN PEPTIDE
- French
- PEPTIDE ANTIGENE DU CANCER A RESTRICTION HLA-A24
Classification
- CPC, 11
- C07K7/06
- A61K38/00
- A61K39/00
- A61K2039/5154
- A61K2039/5156
- A61K2039/53
- C07K7/08
- C07K14/4748
- A61P35/00
- A61K39/001153
- C12N15/11
- IPC, 18
- A61K35 12
- A61K35 76
- A61K38 00
- A61K39 00
- A61P35 00
- C07K7 06
- C07K7 08
- C07K14 47
- C12N1 19
- C12N1 21
- C12N15 12
- C12N5 10
- C07K14 82
- C12P21 02
- C07K16 32
- A61K38 17
- A61K39 395
- A61K31 7088
Designated states1
- Contracting states, 1
- Türkiye
